Free Trial
NASDAQ:TRVN

Trevena (TRVN) Stock Price, News & Analysis

Trevena logo
$0.94 -0.05 (-5.50%)
As of 07/11/2025 12:43 PM Eastern

About Trevena Stock (NASDAQ:TRVN)

Key Stats

Today's Range
$0.94
$0.94
50-Day Range
$0.91
$1.28
52-Week Range
$0.73
$7.85
Volume
462 shs
Average Volume
2,066 shs
Market Capitalization
$896.86 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Hold

Company Overview

Trevena Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
37th Percentile Overall Score

TRVN MarketRank™: 

Trevena scored higher than 37% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Trevena has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Trevena has received no research coverage in the past 90 days.

  • Read more about Trevena's stock forecast and price target.
  • Earnings Growth

    Earnings for Trevena are expected to grow in the coming year, from ($23.04) to ($0.90) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Trevena is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Trevena is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Trevena's valuation and earnings.
  • Percentage of Shares Shorted

    0.38% of the float of Trevena has been sold short.
  • Short Interest Ratio / Days to Cover

    Trevena has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    Trevena does not currently pay a dividend.

  • Dividend Growth

    Trevena does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.38% of the float of Trevena has been sold short.
  • Short Interest Ratio / Days to Cover

    Trevena has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • News Sentiment

    Trevena has a news sentiment score of 1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Trevena this week, compared to 0 articles on an average week.
  • Search Interest

    4 people have searched for TRVN on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Trevena insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.70% of the stock of Trevena is held by insiders.

  • Percentage Held by Institutions

    Only 13.56% of the stock of Trevena is held by institutions.

  • Read more about Trevena's insider trading history.
Receive TRVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trevena and its competitors with MarketBeat's FREE daily newsletter.

TRVN Stock News Headlines

Trevena, Inc. (TRVN) - Yahoo Finance
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
JMP Securities downgrades Trevena (TRVN) to a Hold
Trevena appoints new financial chief
See More Headlines

TRVN Stock Analysis - Frequently Asked Questions

Trevena's stock was trading at $1.50 on January 1st, 2025. Since then, TRVN stock has decreased by 37.7% and is now trading at $0.9352.

Trevena, Inc. (NASDAQ:TRVN) announced its quarterly earnings data on Thursday, August, 8th. The biopharmaceutical company reported ($0.23) earnings per share (EPS) for the quarter, topping the consensus estimate of ($9.25) by $9.02. The biopharmaceutical company had revenue of $0.33 million for the quarter.

Trevena shares reverse split on the morning of Tuesday, August 13th 2024.The 1-25 reverse split was announced on Thursday, August 8th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of TRVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Trevena investors own include Novavax (NVAX), Conatus Pharmaceuticals (CNAT), Sorrento Therapeutics (SRNE), NIO (NIO), TherapeuticsMD (TXMD), Cara Therapeutics (CARA) and SCYNEXIS (SCYX).

Company Calendar

Last Earnings
8/08/2024
Today
7/12/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TRVN
CIK
1429560
Fax
N/A
Employees
40
Year Founded
N/A

Price Target and Rating

High Price Target
$5.00
Low Price Target
$5.00
Potential Upside/Downside
+434.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($47.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$40.29 million
Net Margins
N/A
Pretax Margin
-6,222.30%
Return on Equity
N/A
Return on Assets
-119.55%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.42
Quick Ratio
2.42

Sales & Book Value

Annual Sales
$443 thousand
Price / Sales
2.02
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($11.07) per share
Price / Book
-0.08

Miscellaneous

Outstanding Shares
959,000
Free Float
841,000
Market Cap
$896.86 thousand
Optionable
Optionable
Beta
0.61

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:TRVN) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners